Clinical Trials Browser

Triple Negative Breast Neoplasms × trametinib × Gynecologic × Clear all

NCT01138085 2017-11-13

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

Phase 1 Completed

BreastGynecologic

Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms